Why the study?
Does combined antiplatelet therapy with ticlopidine and aspirin prevent stent thrombosis and bleeding in patients after coronary stent implantation?
Population
529 consecutive patients who underwent successful coronary stenting with conventional stents, including 112…
Design
Cohort
Authors
Loading...
Supports dual antiplatelet feasibility in elective stenting; leaves open optimal regimens for bailout cases with elevated events.
Does combined antiplatelet therapy with ticlopidine and aspirin prevent stent thrombosis and bleeding in patients after coronary stent implantation?
Combined antiplatelet therapy with ticlopidine and aspirin without oral anticoagulation is feasible and associated with low rates of stent thrombosis and bleeding after coronary stenting.
Lablanche et al. (1996) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: